Trade KVUE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Kenvue Inc. (KVUE) is trading at US$19.17, down 0.16% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$36.61B. Over the past 52 weeks, KVUE has traded between US$14.02 and US$20.82. On Syfe you can trade KVUE with $0 commission and add it to your watchlist.
| Previous close | US$19.20 |
|---|---|
| Market cap | US$36.61B |
| P/E ratio | 15.66 |
| 52-week range | US$14.02 – US$20.82 |
| Dividend yield | 4.34% |
| Volume | 11.89M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kenvue Inc.
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.
Year: 2023
Kenvue Inc. (KVUE) stock is trading at US$19.17, -0.16% from the previous close of US$19.20.
The market cap for Kenvue Inc. (KVUE) stock is approximately US$36.61B.
The price-to-earnings ratio for Kenvue Inc. (KVUE) is 15.66, based on the latest reported earnings.
The 52-week high for Kenvue Inc. (KVUE) stock is US$20.82.
The 52-week low for Kenvue Inc. (KVUE) stock is US$14.02.
Yes, Kenvue Inc. (KVUE) pays a dividend. The trailing 12-month dividend yield is 4.34%.
Stay on top of KVUE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
